13 May 2014 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International plans to "improve" its merger proposal to Allergan after the board of the Botox maker "unanimously rejected the unsolicited proposal".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.